Patients receiving medication-assisted treatment (MAT) combined with counseling for opioid use disorder (OUD) see significant improvements – not only in drug-use reduction, but also in mental health, legal issues and interpersonal relationships. That’s according to a new white paper from Baymark Health Services, which found that illicit drug use decreases by 65% over the first […]
The federal government gave the behavioral health industry a behind-the-scenes look at its strategic priorities for the coming years earlier this month. Those priorities, outlined by the Substance Abuse and Mental Health Services Administration (SAMHSA), include a push to better integrate behavioral health care into physical health care — and the other way around. Other […]
Within the behavioral health sector, it has been a bumpy 12 months for autism treatment providers. But it’s turning out to be somewhat of a tumultuous year for those in the substance use disorder (SUD) space as well. SUD dealmaking fell below pre-pandemic levels in Q1, according to a recent report by M&A advisory firm […]
Monte Nido hires new COO Giulia Peterlongo has begun her new role as the chief operating officer at eating disorder provider Monte Nido & Affiliates. Before joining Monte Nido, Peterlongo worked for DaVita Kidney Care for almost seven years, recently serving as division vice president. She previously served as a health care specialist at McKinsey […]
Federal lawmakers introduced a new bill that would loosen regulations on methadone prescribing. Legislators released the Modernizing Opioid Treatment Access Act in the U.S. House of Representatives and the Senate. A bipartisan group announced the bill, saying it would be vital in expanding care for opioid use disorder (OUD). “This legislation lowers barriers to care […]
The federal government now allows any appropriately registered prescribers to use buprenorphine to treat patients with opioid use disorder (OUD) after years of loosening restrictions on the drug. Several behavioral health insiders see the move as having clear benefits for the industry. However, the benefit of deregulating buprenorphine may underwhelm in the short-term and even […]
In 2023, substance use disorder (SUD) executives forecast retaining and recruiting challenges, more modality flexibility, deeper adoption of data and value-based care and shifting regulatory frameworks. Behavioral Health Business reached out to top executives in the substance use disorder space to get their insights on two key questions — What will be the defining market […]
As the Federal Reserve continues to raise interest rates, many behavioral health stakeholders are tightening their belt on merger and acquisition deals. But for providers with cash, it could be a prime time to strike. “What we’re seeing when we are out talking about acquisitions is that people are dropping out quicker and they don’t […]
Primary care has historically been at the heart of value-based care agreements. The growing emphasis on holistic care could leave the door open for more collaborative care models that include both behavioral and physical health. A key part of that move is more partnerships between primary care operators and mental health providers, industry insiders believe. […]
Across behavioral health, dealmaking and investing in 2022 likely won’t reach the remarkable levels seen in 2021. Regardless, there are several reasons to expect that this year will continue to demonstrate that the investment and M&A markets are on the side of behavioral health providers, according to Dexter Braff, the president of the M&A firm […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
